Research Synthesis: Resveratrol Intervention Resveratrol Supplementation Effects — full paper

Researka accepted publication: 64624378-99b2-4428-8eb3-b291c8a1215f Source submission: 65247057-0ba0-436e-86eb-575a1bc009f4 Evidence-honesty note: 9/12 retained sources are indirect, review-level, adjacent, or mechanistic and are used only to bound interpretation. The conclusion therefore does not support broad causal, clinical, or policy claims. This synthesis tests the thesis that evidence for Resveratrol Supplementation Effects is context-dependent, separating outcome-specific signals from broader claims and identifying the evidence gaps that should bound interpretation. Resveratrol, a polyphenol with purported anti-inflammatory and antioxidant properties, has been extensively investigated for its potential benefits in cardiometabolic and immune-related conditions, yet the clinical evidence remains heterogeneous across populations and dosing regimens. This synthesis employed an AI-assisted structured evidence synthesis approach with an audit trail to integrate findings from 12 curated reference papers spanning systematic reviews, meta-analyses, and randomized controlled trials to evaluate resveratrol supplementation effects. These immune outcomes show a more consistent positive signal compared to cardiometabolic endpoints, with agreement across both the meta-analytic and direct RCT evidence (Tabrizi 2018; Keramatzadeh 2025).